Bio-Medical Applications Of Pennsylvania Inc is categorized under Kidney Dialysis Centers in Wilkes Barre, PA .
Bio-Medical Applications Of Pennsylvania Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Leonard Baiera at the company’s branch by writing to 307 Laird St # 1, Wilkes Barre, Pennsylvania PA 18702 or by phoning (570) 825-9531. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Medical Applications Of Pennsylvania Inc |
| Contact Person: | Leonard Baiera |
| Address: | 307 Laird St # 1, Wilkes Barre, Pennsylvania 18702 |
| Phone Number: | (570) 825-9531 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Bio-Medical Applications Of Pennsylvania Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Leonard Baiera for inquiries that concern Bio-Medical Applications Of Pennsylvania Inc by calling the company number (570) 825-9531, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Pennsylvania Inc can be found at the coordinates 41.256554,-75.828645 as well as the street address 307 Laird St # 1 in Wilkes Barre, Pennsylvania 18702.
For its online presence, you may visit Bio-Medical Applications Of Pennsylvania Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.